Download Free Medical Covid-19 Outbreak & Business Continuity - 4 Practical Recommendations PowerPoint Presentation

Covid-19 Outbreak & Business Continuity - 4 Practical Recommendations PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : The coronavirus Covid-19 outbreak is causing an exponential increase of deaths. To restrict this governments around the globe are obliged to make drastic decisions to limit the spread of the virus in their country. To help pharma companies efficiently run their operations in a context of social-distancing and closure measures, This Smart Pharma position paper proposes 4 practical recommendations.

Tags : Covid-19, coronavirus, pharma companies, Pharma, pharmaceutical, Pharmaceutical Industry

Published on : Jun 29, 2020 | Views : 2868 | Downloads : 0

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

1, rue Houdart de Lamotte – 75015 Paris – France Tel. +33 6 11 96 33 78 Email : jmpeny@smart-pharma.com – Website : www.smart-pharma.com March 17, 2020 Covid-19 & Business Continuity – 4 Practical Recommendations Covid-19 Outbreak & Business Continuity Position Paper March 17, 2020 4 Practical Recommendations SMART TOOL SERIES (#2)
Slide 2-

1 As of March 16, 2020 – 2 Diabetes, cardiac diseases, respiratory failure – 3 80 years old or more – 4 The geographical areas where the virus is circulating Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 2 ̶ Stage 2: The strategy consists in slowing down the spread of the virus by identifying clusters4 and limiting contacts with non-infected people by social-distancing (e.g. limiting people gathering) and closure policies (e.g. schools) Covid-19 & Business Continuity 1. Introduction The Covid-19 outbreak is leading to an exponential increase of deaths which has obliged governments to make drastic decisions to limit the propagation of the virus in their country The Coronavirus disease 2019 (Covid-19) has spread in 124 countries and led to 6,500 deaths1, especially amongst patients suffering from chronic diseases2 and/or very old ones3 Governments have implemented different strategies according to the stage of the outbreak: ̶ Stage 1: The priority is to control the entry of infected people in the country through early identification ̶ Stage 3: This third stage corresponding to the circulation of the virus across the country, the strategy is to reduce clusters of cases and mobilize healthcare structures and healthcare professionals to limit the possible lethal effects of the virus Sources: Smart Pharma Consulting after WHO-China Joint Mission report on Covid-19, February 2020 – WHO data, March 2020 – CNN, March 2020 WHO
Slide 3-

1 France, Germany, Italy, Spain. In the UK, the government has not yet opted for mass closures but for more targeted measures, like asking people with respiratory symptoms to stay at home – 2 Medical Reps, Medical Science Liaisons, Key Account Managers, Key Institution Managers, etc. Covid-19 & Business Continuity 1. Introduction To help pharma companies run their operations, as efficiently as possible, in a context of social-distancing and closure measures, Smart Pharma proposes 4 practical recommendations The business continuity of companies is getting affected by social-distancing measures and closure policies implemented by governments in the USA, the top 5 European countries1, China and Japan which together account for ~75% of the worldwide pharma market in value In addition to these measures, several pharma companies have self-imposed even more restrictive measures such as: Travel restrictions Working from home to reduce virus transmission between colleagues and for in-field employees2 to or from healthcare professionals These restrictions will be soon applied by a much larger number of pharma companies which must however continue to ensure their operations are run with as much as possible efficiency For so doing, Smart Pharma Consulting proposes – a non-exhaustive – list of 4 practical recommendations which can be easily and immediately implemented Sources: Smart Pharma Consulting after FirstWord, March 10, 2020, The New York Times, March 14, 2020 Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 3
Slide 4-

Covid-19 & Business Continuity 1. Introduction We have selected four themes for which we propose recommendations, especially for affiliates of pharma companies particularly affected by measures related to the Covid-19 outbreak Sources: Smart Pharma Consulting “Covid-19 situation will offer opportunities to open-minded managers with an entrepreneurial mindset” Activities Prioritization E-Meeting Management HCP Relationship Management Collaborators Engagement Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 4
Slide 5-

1 Dwight D. Eisenhower was the 34th President of the United States from 1953 to 1961. Before becoming President, he served as a five-star general in the United States Army and as the Allied Forces Supreme Commander in Europe during World War II. He also later became NATO’s first Supreme Commander Sources: Smart Pharma Consulting Covid-19 & Business Continuity 2. Recommendations The Eisenhower Matrix is a practical and easy-to-use tool to help select activities to focus on and those to postpone or cancel Activities Prioritization (1/2) When resources cannot be optimally mobilized, prioritization is more than ever essential, without compromising on quality Postpone Do immediately Cancel or do during spare time Delegate to someone Urgent Important Make a specific to-do list with all the things to get done Not important P1 P3 P2 P4 This Matrix is a tool to prioritize activities based on importance and urgency Important activities contribute to meet long-term goals and urgent ones to meet short-term goals, requiring immediate action A great attention should be paid at evaluating: What activities should be done? When and by whom? This matrix helps sort out activities to focus on and those that should be postponed or even ignored A daily, weekly, monthly… schedule of activities will be set considering their degree of priority based on importance and urgency P Priority ranking Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 5 Eisenhower1 Matrix Not urgent
Slide 6-

1 From P1 to P4 as per the Eisenhower Matrix – 2 Such creativity sessions, decision-making activities, complex analyses, assessment of collaborators performance, etc. – 3 Such as a simple Excel spreadsheet, Outlook or a more specific tool like Trello, Taskworld Sources: Smart Pharma Consulting Covid-19 & Business Continuity 2. Recommendations Take time to plan carefully your activities and you will end up saving time Activities Prioritization (2/2) Activity Planning Tools Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 6
Slide 7-

1 Only necessary people should be invited. People may be invited for only part of the meeting – 2 Someone who ensures that there is a linkage between all participants, making sure that everyone can hear, see and speak – 3 This role can be assigned to a participant or a technician who does not attend the meeting but who can be contacted for immediate help to address technical problems Sources: Smart Pharma Consulting 2. Prepare & send a detailed agenda Setting clear meeting goals will help define who should attend A detailed agenda, with timelines (considering different time zones, if any) should be defined and sent to participants1 in advance… … along with background information and their respective role, for review and preparation Participants should get the information to call into the meeting Some of them will be assigned responsibilities such as: facilitator, time-keeper, note-taker, bridge moderator2, technical support3 The most widely used tools for video conferences, in business environment are: Zoom, Skype (Microsoft), Webex (Cisco), knowing none of them is free from dysfunction The host will check, few minutes ahead of time, that the teleconference tool works properly, so that to start on time 3. Communicate what is expected from participants 1. Communicate the goals of the meeting 4. Send participants call-in information / access codes 5. Assign responsibilities to participants 6. Use a proper video conference software 7. Open the session 2-3 minutes ahead of time Covid-19 & Business Continuity 2. Recommendations If well-prepared and properly managed to keep all participants engaged, E-meeting may be as effective as face-to-face meetings, while saving time and money E-Meeting Management (1/2) Social-distancing and closure measures to limit transmission of the Covid-19 oblige companies to replace face-to-face meetings by virtual or remote meeting 7 Tips for Proper E-meeting Preparation Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 7
Slide 8-

1 Presentations should not last more than 20 minutes. Background information can be sent in advance to participants Covid-19 & Business Continuity 2. Recommendations The strict implementation of the following 10 tips will help run successfully E-meetings Sources: Smart Pharma Consulting, Bob Frisch & al. HBR, March 05, 2020 E-Meeting Starter E-Meeting Running E-Meeting Follow-up 1. Use an icebreaker to create a positive atmosphere and get people on board 2. Recall the goals of the e-mail and what is expected from each participant 3. Show the agenda (with short breaks of 5-10 minutes every hour or hour and half) 4. Set meeting ground rules Maximize discussion time over presentation time1 Give a chance to each participant to express himself Avoid people speaking over each other by ensuring a strict application of E-meetings ground rules Keep participants engaged and the meeting interactive by: Making short talk Calling on them to give regularly their opinion Using video (shared screen, camera, etc.) Putting the microphone on mute when not talking to avoid background noise Send a clear – precise – concise follow-up e-mail that summarizes: Key information shared Decisions made Key takeaways Actions to be carried out and by whom 10. A minute will be sent out to people who need to be kept informed about the outcomes E-Meeting Management (2/2) 10 Tips to well-run an E-meeting Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 8
Slide 9-

In the context of the Covid-19 outbreak, in-field collaborators1 are facing strong difficulties to maintain interactions with HCPs HCPs can adopt 4 behaviors vis-à-vis in-field collaborators: Refuse all types of interactions with in-field collaborators Accept F/F (face-to-face) interactions only Accept E-interactions (i.e. remote) only Accepts F/F and E-interactions In-field collaborators can adopt 3 behaviors: Accept F/F interactions only Accept E-interactions only Accept F/F and E-interactions The challenge for pharma companies is to remain connected with their “clients” by adopting the appropriate behavior   E-Interactions F/F Interactions In-field collaborators Healthcare Professionals F/F Interactions E- Interactions No Interactions Covid-19 & Business Continuity 2. Recommendations Pharma companies should consider the individual position of HCPs and of their in-field collaborators before deciding which strategy to adopt to stay connected to their “clients” HCP Relationship Management (1/2) Social-distancing measures and HCPs increasing workloads due to the Covid-19 outbreak prevent in-field collaborators from maintaining regular contacts with their “clients” Situation Analysis Sources: Smart Pharma Consulting 1 Medical Reps, Medical Science Liaisons, Key Account Managers, Key Account Managers, Key Institution Managers, etc. Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 9
Slide 10-

1 See the position paper “Excellence in Execution Applied to Pharma Companies “ on Smart Pharma Consulting website: https://smart-pharma.com/wp-content/uploads/2019/07/Smart-Management-Series-Excellence-in-Execution-VWF.pdf Sources: Smart Pharma Consulting Covid-19 & Business Continuity 2. Recommendations The offering of high-value services to support HCPs, patients and/or medical institutions in the context of the Covid-19 outbreak, may be rewarding for pharma companies, if well executed HCP Relationship Management (2/2) Brand Preference Mix (BPM)1 Covid-19 Outbreak-related Services Social-distancing and closure measures in place in most countries affected by the Covid-19 have compelled employees to stay at home This unfortunate situation may be an opportunity for pharma companies to offer HCPs, patients and/or institutions new services The proposed services should respond to a real need and be preferably connected to the management of the Covid-19 outbreak Pharma companies and their collaborators should be: Legitimate to offer these services Capable to deliver a high level of service quality In-field collaborators are best positioned to identify possible services Unsolicited communication on non-essential and urgent information regarding promoted brands would be viewed as inappropriate The BPM determines the 3 drivers to be activated to enhance prescriber preference, and thus to optimize market share1 In the Covid-19 context, priority should be given at offering services in relation to the outbreak Corporate reputation Service quality Brand attributes In-field collaborators Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 10
Slide 11-

1 Especially when collaborators feel anxious and/or are not used to work from home Sources: Smart Pharma Consulting Start and end your day with a routine (e.g. preparing a coffee, shutting down the computer) that defines the workday Schedule breaks (e.g. one or two breaks of 10 minutes in the morning and the afternoon, plus a 45 to 60 minutes lunch break) Set ground rules with household members (especially if schools and day care are closed) so that to remain concentrated on your work Keep a dedicated office space for work and use a noise-canceling headphone to avoid getting distracted by family members Get the right equipment (e.g. a monitor for your laptop, a printer, a proper access to Internet, a webcam) and the right applications (e.g. Microsoft Teams, Skype, GoTOMeeting, Zoom, Slack) to facilitate remote interactions Interact regularly with your colleagues and manager to prevent loneliness which makes people feel less motivated and productive Get clear objectives from your manager while working from home, and set up frequent (daily or at least weekly) progress meetings 7 Tips to Working from Home Effectively Covid-19 & Business Continuity 2. Recommendations While collaborators are encouraged or requested to work from home, their manager must be particularly supportive1 and communicate regularly to reassure them and give precise direction Collaborators Engagement (1/2) As the Covid-19 continues to spread, governments and companies are asking people to work remotely, as much as possible, which is a real challenge in terms of motivation and engagement Office-based Employees In-field Employees No or very limited F/F interactions with HCPs Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 11 No or very limited F/F interactions with colleagues
Slide 12-

1 These three suggestions are not exhaustive. Depending on companies' specific business situation, some other priorities could be considered to maintain collaborators engagement and thus business continuity – 2 The Training Programs proposed by Smart Pharma Consulting can be customized and transformed in E-learning programs in 3 days: https://smart-pharma.com/wp-content/uploads/2019/08/Catalogue-Training-Programs-2020-VW-1.pdf Sources: Smart Pharma Consulting Covid-19 & Business Continuity 2. Recommendations Collaborators could be proposed online training to further develop their skills, spend time on planning activities and be involved in a contest to propose better ways of doing business Collaborators Engagement (2/2) 3 Suggestions to keep Collaborators Engaged and Productive1 Set up Online Trainings Give Priority to Planning Activities Launch a Creative Business Operation Contest The Covid-19 crisis offers an opportunity to propose online training courses to collaborators These E-learning programs should be designed considering that most collaborators work from home2 No compromise on the quality of the program should be accepted… … nor on the relevance for the employees to undergo a specific training The disruption created by the Covid-19 outbreak is conducive to rethink business operation status quo Companies should launch a “creativity contest” for its collaborators to find new ways of doing business, along their value chain, so that to: Increase their operational efficacy and efficiency Better interact with and serve their “clients” In general, planning activities are not devoted enough attention due to the daily workload of collaborators The crisis leading to cancelation of many meetings, the time freed up could be invested to raise the quality of plans (e.g. brand plans, in-field collaborators action plans) by: Revisiting the existing ones Devoting more time at developing new ones Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 12
Slide 13-

1 Such as drug manufacturing and distribution, pharmacovigilance, medical information Sources: Smart Pharma Consulting Covid-19 & Business Continuity 3. Key takeaways These recommendations intend to help pharma companies ensure the continuity of their business while complying with their internal rules and the national measures imposed by governments Our 4 Practical Recommendations Activities Prioritization E-Meeting Management HCP Relationship Management Collaborators Engagement Priority activities, in the context of Covid-19 outbreak, are those contributing firstly to protect the companies’ collaborators, their families and clients… … and secondly to maintain the continuity of the business by ensuring the essential tasks1 The generalization of E-meetings, during the Covid-19 crisis, requires to train all collaborators on “best practices”… … and to strictly apply the corresponding rules to ensure their efficacy and efficiency Face-to-face interactions with HCPs becoming very difficult, if not impossible,… … in-field collaborators should try to remain connected by proposing services to help better manage the Covid-19 outbreak Collaborators, not familiar with work from home, should receive guidance and advice to adjust and be productive They should be proposed online trainings, devote time to build high-quality plans and participate to a “Creative Business Operation” contest ; to make the best use of time Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020 13
Slide 14-

Consulting firm dedicated to the pharmaceutical sector operating in the complementary domains of strategy, management and organization Smart Pharma Consulting Editions Besides our consulting activities which take 85% of our time, we are strongly engaged in sharing our knowledge and thoughts through: Our teaching and training activities The publication of articles, booklets, books and expert reports As of today, more than 80 publications in free access can be downloaded from our website Since 2012, we have published: 18 business reports (e.g. The French Pharma Market) 9 position papers in the “Best-in-Class Series” 6 position papers in the “Smart Manager Series” 2 position papers in the “Smart Tool Series” Our research activities in pharma business management and our consulting activities have shown to be highly synergistic We hope that this new publication will be useful for you We remain at your disposal to carry out consulting projects or training seminars to help you improve your operations Best regards Jean-Michel Peny The Smart Tool Series This new series intends to provide practical tools and recommendations to enhance the efficacy and efficiency of the most important activities or processes in place within pharma companies Our tools and recommendations are based on both: Our consulting experience in the pharma sector Our research for innovative, pragmatic and useful solutions Each issue of this new series has been designed to be read in 15 to 20 minutes and not to exceed 20 pages Issue #2: Covid-19 Outbreak & Business Continuity 4 Practical Recommendations The social-distancing and closure actions taken to limit the Covid-19 transmission are creating strong operational disruptions We propose 4 practical recommendations to ensure, as much as possible, business continuity This crisis could offer opportunities for companies to rethink the way they run their operations and to find innovative solutions Covid-19 & Business Continuity – 4 Practical Recommendations March 17, 2020

User Presentation
Related Presentations

Medication Therapy Management Part D Programs

By: MattB
Views: 2031

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 5

By: MattB
Views: 2416

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 2

By: MattB
Views: 3093

Drug Development with Dutch Public Funding

By: MattB
Views: 1656

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.5

By: MattB
Views: 2427

General Pharmacokinetics

By: JenniferDwayne
Views: 2892

Pharmacovigilance and Safety Monitoring For Herbal Medicinal Products

By: KhushbuSG
Views: 1758

Molecular Targets in Cancer Drug Development Access to Precision Medicine for Children with Cancer

By: JenniferDwayne
Views: 1853

Pharmacology introduction

By: drdwayn
Views: 2823

Pharmacovigilance in Clinical Trials

By: yourdoctors
Views: 2336

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z